Over 90% of drugs fail in clinical trials, largely due to the limited representativeness of preclinical models. Traditional models, whether animal or in vitro, fail to effectively capture the complexity and genetic diversity of humans.
At Invitrall, we are overcoming this challenge. We develop advanced disease in vitro models that represent human genetic diversity, providing innovative solutions to test the safety and efficacy of pharmaceutical and cosmetic products. Our technology bridges the gap left by traditional experimental models, helping to accelerate the development of therapies for various diseases.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Curitiba, Paraná, Br
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://invitrall.com/
- Keywords
- Mendoza.
- HQ
- Curitiba, Paraná
Invitrall Questions
Invitrall's website is https://invitrall.com/
Invitrall's LinkedIn profile is https://br.linkedin.com/company/invitrall
Invitrall has
3 employees.
View email and phone details for 3
employees at Invitrall.
Invitrall's industry is
Biotechnology Research
Invitrall's top competitors are
Migma,
Bioblends,
Microin,
Bioplastix,
Cyanomin,
Polymera,
Biodiversity Intelligence,
Cellrep,
Scitherm,
Apasomics.
Invitrall's categories are Biotechnology Research
Invitrall's founding year is 2024
